Gain Therapeutics Inc (GANX)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Revenue | 0 | 0 | 55k | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.75M | -4.56M | -5.23M | -7.73M | -4.89M | -4.41M | -4.38M | -8.18M |
Pre Tax Income | -4.55M | -4.6M | -5.12M | -7.66M | -4.7M | -4.71M | -3.99M | -8.14M |
Net Income | -4.56M | -4.68M | -5.14M | -7.69M | -4.72M | -4.57M | -4.01M | -8.14M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -4.75M | -4.56M | -5.23M | -7.73M | -4.89M | -4.41M | -4.38M | -8.18M |
EBITDA | -4.75M | -4.54M | -5.21M | -7.71M | -4.86M | -4.38M | -4.36M | -8.16M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 41k | 29k | 196k | 140k | 55k |
Operating Income | -2.1M | -3.48M | -13.8M | -17.78M | -22.25M |
Pre Tax Income | -2.19M | -3.57M | -13.86M | -17.5M | -22.19M |
Net Income | -2.19M | -3.58M | -13.86M | -17.59M | -22.11M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.975 | -0.889 | -1.166 | -1.48 | -1.713 |
EBIT | -2.1M | -3.48M | -13.8M | -17.78M | -22.25M |
EBITDA | -2.1M | -3.47M | -13.78M | -17.71M | -22.17M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.